ALLGENESIS
Live / Registered — Registered — Section 8 accepted (as of 25 Jul 2025)
What this means for you
Registered since 26 Mar 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Mar 2029: the §8 & §9 renewal).
Record
- Serial number
- 87741560
- Registration number
- 5707152
- Mark type
- Word mark
- Filed
- 03 Jan 2018
- Published for opposition
- 23 Oct 2018
- Registered
- 26 Mar 2019
- Next maintenance filing
- §8 & §9 renewal, due by 26 Mar 2029 (grace period to 26 Sept 2029)
- Attorney of record
- Andrew Auderieth
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of ophthalmic and central nervous system (CNS) diseases for human purposes [ ; Diagnostic test reagents for medical purposes ]
Owner
- Allgenesis Biotherapeutics Inc., Songshan Dist., Taipei, TW
- Allgenesis Biotherapeutics Inc., Songshan Dist., Taipei, TW
- Allgenesis Biotherapeutics Inc., Songshan Dist., Taipei, TW
Prosecution history
- 25 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 25 Jul 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 20 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 14 Apr 2025 — POST REGISTRATION ACTION MAILED - SEC. 8
- 10 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Sept 2024 — TEAS SECTION 8 RECEIVED
- 26 Mar 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
- 15 Feb 2019 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 06 Feb 2019 — NOTICE OF ALLOWANCE CANCELLED
- 15 Feb 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Feb 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jan 2019 — TEAS DELETE 1(B) BASIS RECEIVED
- 18 Dec 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED